MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants

Overview of attention for article published in Frontiers in immunology, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 16 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Researchers develop a universal SARS-CoV-2 neutralizing antibody

The Medical News, 13 Dec 2021

Many antibody therapeutics have been developed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.